Impact of Agent Orange on U.S. Veterans
In 2010, the U.S. Department of Veterans Affairs provided $16.2 billion in compensation to 1,095,473 Vietnam-era veterans. The agency does not relate these service-connected benefit figures directly to Agent Orange/dioxin exposure or to any other possible cause of illness, nor does it provide data on total compensation for the years since the war ended.
Thousands of U.S. veterans returning from Vietnam reported health problems almost immediately and rapidly associated them with Agent Orange/dioxin exposure. Controversy over these assertions began just as fast, and continues now.
Many questions remain:
- Whether (and how to test whether) the illnesses of veterans and their offspring are related to Agent Orange and other herbicide exposure;
- Levels of dioxin present in the chemicals;
- The accuracy of data about veterans’ exposure;
- Levels of corporate, military and government awareness of dioxin’s presence;
- Fixing of responsibility for the contaminant’s presence and liability for its damages;
- Details of research protocols, accuracy of findings and reliability of interpretations; and
- Decisions on who should pay what to whom for which possible courses of remedial action.
This “blame game” has blocked action in both the U.S. and Vietnam, needlessly prolonging the suffering of millions of U.S. veterans and Vietnamese.
The current U.S. government position on Agent Orange/dioxin damage to U.S. veterans:
In the Agent Orange Act of 1991, Congress required the National Academy of Sciences to review periodically all medical and scientific research on the health effects of exposure to Agent Orange/dioxin and other chemicals used during the Vietnam War, and to their individual components. The NAS Institute of Medicine now issues biennial reports called Veterans and Agent Orange. The most recent one was issued in July 2009.
- The U.S. Department of Veterans Affairs now allows compensation to anyone who had “boots on the ground” in Vietnam or served on particular U.S. Navy ships offshore from 1962 to 1975 (about 2.8 million people) and suffers from any of these diseases: soft-tissue sarcoma, non-Hodgkins lymphoma, Hodgkin’s disease, chloracne, chronic lymphocytic leukemia, respiratory cancer, prostate cancer, multiple myeloma, amyloidosis, peripheral neuropathy, porphyria cutanea tarda, type II diabetes, and spina bifida in offspring.
- Parkinson’s Disease, hairy cell leukemia and ischemic heart disease were added to this list in
- The VA also allows compensation for children of female veterans who served in Vietnam who have achondroplasia, cleft lip or cleft palate, congenital heart disease, clubfoot, esophageal and intestinal atresia, Hallerman-Streiff syndrome, hip dysplasia, Hirschsprung Disease, hydrocephalus, hypospadias, imperforate anus, neural tube defects (including spina bifida, encephalocele, and anencephaly), Poland syndrome, pyloric stenosis, fused digits, tracheal or esophageal fistula, undescended testicle and Williams syndrome.
- All U.S. compensation is for service in Vietnam and is not specifically linked to exposure to any of the herbicides or to dioxin.
The U.S. government has consistently stated that no scientific evidence links Agent Orange/dioxin to adverse health effects found in Vietnam. However, U.S. officials have begun dialogue with Vietnamese counterparts about a humanitarian approach to the issue. In addition, Congress has appropriated $40.1 million since 2007 for environmental remediation of dioxin-contaminated sites and for related health activities, on a humanitarian basis.